BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 33658844)

  • 1. The Impact of AC and AC-T Chemotherapy's Toxicities on Quality of Life Among Women with Breast Cancer in Ethiopia: A Prospective Patient-Reported Outcomes Study.
    Gadisa DA; Wang SH; Yimer G
    Breast Cancer (Dove Med Press); 2021; 13():107-132. PubMed ID: 33658844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reliability and validity of Amharic version of EORTC QLQ-C30 and QLQ-BR23 modules for assessing health-related quality of life among breast cancer patients in Ethiopia.
    Gadisa DA; Gebremariam ET; Ali GY
    Health Qual Life Outcomes; 2019 Dec; 17(1):182. PubMed ID: 31830992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicity profile of Doxorubicin-Cyclophosphamide and Doxorubicin-Cyclophosphamide followed by Paclitaxel regimen and its associated factors among women with breast cancer in Ethiopia: A prospective cohort study.
    Gadisa DA; Assefa M; Wang SH; Yimer G
    J Oncol Pharm Pract; 2020 Dec; 26(8):1912-1920. PubMed ID: 32122234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
    Andre T; Amonkar M; Norquist JM; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt CJA; Smith D; Garcia-Carbonero R; Sevilla I; De La Fouchardiere C; Rivera F; Elez E; Diaz LA; Yoshino T; Van Cutsem E; Yang P; Farooqui M; Le DT
    Lancet Oncol; 2021 May; 22(5):665-677. PubMed ID: 33812497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of pembrolizumab versus chemotherapy on health-related quality of life in patients with metastatic triple-negative breast cancer: results from the phase 3 randomised KEYNOTE-119 study.
    Schmid P; Lipatov O; Im SA; Goncalves A; Muñoz-Couselo E; Lee KS; Tamura K; Testa L; Witzel I; Ohtani S; Turner N; Zambelli S; Harbeck N; Andre F; Dent R; Mejia JA; Zhou X; Haiderali A; Nguyen AM; Cortes J; Winer EP
    Eur J Cancer; 2023 Dec; 195():113393. PubMed ID: 37976633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Worsening of rest-activity circadian rhythm and quality of life in female breast cancer patients along progression of chemotherapy cycles.
    Sultan A; Choudhary V; Parganiha A
    Chronobiol Int; 2017; 34(5):609-623. PubMed ID: 28276853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resilience and Quality of Life in Breast Cancer Patients.
    Ristevska-Dimitrovska G; Filov I; Rajchanovska D; Stefanovski P; Dejanova B
    Open Access Maced J Med Sci; 2015 Dec; 3(4):727-31. PubMed ID: 27275317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of anticancer therapy on the quality of life of Sudanese patients with breast cancer at Khartoum oncology hospital.
    Aldaak M; Suliman HM; Abd-Elgadir EE; Abdoon IH
    BMC Womens Health; 2022 Nov; 22(1):448. PubMed ID: 36376816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between Diabetes and Quality of Life among Breast Cancer Survivors.
    Tang Z; Wang J; Zhang H; Sun L; Tang F; Deng Q; Yu J
    PLoS One; 2016; 11(6):e0157791. PubMed ID: 27333326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Quality of life in Mexican women with breast cancer at different stages and its association with sociodemographic characteristics, comorbidities and procedural factors at the Mexican Institute of Social Security].
    Sat-Muñoz D; Contreras-Hernández I; Balderas-Peña LM; Hernández-Chávez GA; Solano-Murillo P; Mariscal-Ramírez I; Lomelí-García M; Díaz-Cortés MA; Mould-Quevedo JF; López-Mariscal AR; Prieto-Miranda SE; Morgan-Villela G
    Value Health; 2011; 14(5 Suppl 1):S133-6. PubMed ID: 21839887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of quality of life (QoL) in breast cancer patients by using EORTC QLQ-C30 and BR-23 questionnaires: A tertiary care center survey in the western region of Saudi Arabia.
    Imran M; Al-Wassia R; Alkhayyat SS; Baig M; Al-Saati BA
    PLoS One; 2019; 14(7):e0219093. PubMed ID: 31291302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis.
    Ferreira AR; Di Meglio A; Pistilli B; Gbenou AS; El-Mouhebb M; Dauchy S; Charles C; Joly F; Everhard S; Lambertini M; Coutant C; Cottu P; Lerebours F; Petit T; Dalenc F; Rouanet P; Arnaud A; Martin A; Berille J; Ganz PA; Partridge AH; Delaloge S; Michiels S; Andre F; Vaz-Luis I
    Ann Oncol; 2019 Nov; 30(11):1784-1795. PubMed ID: 31591636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of Life among Breast Cancer Patients In Malaysia.
    Ganesh S; Lye MS; Lau FN
    Asian Pac J Cancer Prev; 2016; 17(4):1677-84. PubMed ID: 27221837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-Sectional Patient-Reported Outcome Measuring of Health-Related Quality of Life With Establishment of Cancer- and Treatment-Specific Functional and Symptom Scales in Patients With Penile Cancer.
    Draeger DL; Sievert KD; Hakenberg OW
    Clin Genitourin Cancer; 2018 Dec; 16(6):e1215-e1220. PubMed ID: 30201215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Patient-Reported Quality of Life of Anal Cancer Survivors Treated With Intensity Modulated Radiation Therapy and Concurrent Chemotherapy: Results From a Prospective Phase II Trial.
    Joseph K; Balushi MA; Ghosh S; Stenson T; Abraham A; Elangovan A; Warkentin H; Paulson K; Tankel K; Usmani N; Severin D; Schiller D; Wong C; Mulder K; Doll C; King K; Nijjar T
    Int J Radiat Oncol Biol Phys; 2023 Oct; 117(2):434-445. PubMed ID: 37148982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the Impact of Organ Failure and Metastases on Quality of Life in Breast Cancer Patients: A Prospective Study Based on Utilizing EORTC QLQ-C30 and EORTC QLQ-BR45 Questionnaires in Romania.
    Ionescu Miron AI; Anghel AV; Antone-Iordache IL; Atasiei DI; Anghel CA; Barnonschi AA; Bobolocu AM; Verga C; Șandru F; Lișcu HD
    J Pers Med; 2024 Feb; 14(2):. PubMed ID: 38392647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of EORTC QLQ-C30 and QLQ-BR23 questionnaires in the measurement of quality of life of breast cancer patients in Singapore.
    Tan ML; Idris DB; Teo LW; Loh SY; Seow GC; Chia YY; Tin AS
    Asia Pac J Oncol Nurs; 2014; 1(1):22-32. PubMed ID: 27981079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life of Croatian breast cancer patients receiving adjuvant treatment--comparison to long-term breast cancer survivors.
    Murgić J; Soldić Z; Vrljić D; Samija I; Kirac I; Bolanca A; Kusić Z
    Coll Antropol; 2012 Dec; 36(4):1335-41. PubMed ID: 23390830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicity and quality of life of Korean breast cancer patients treated with docetaxel-containing chemotherapy without primary G-CSF prophylaxis.
    Lee J; Ahn MH; Jang YH; Lee EJ; Park JH; Rho J; Kim Z; Kim HM; Han SW; Lim C; Lee MH; Kim SY
    Breast Cancer; 2014 Nov; 21(6):670-6. PubMed ID: 23371824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-related quality of life and its predictors among patients with breast cancer at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia.
    Sibhat SG; Fenta TG; Sander B; Gebretekle GB
    Health Qual Life Outcomes; 2019 Nov; 17(1):165. PubMed ID: 31690327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.